| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99285 |
|
7,457 |
6,561 |
$2.25M |
| 99284 |
|
8,749 |
8,218 |
$1.52M |
| 99283 |
|
9,002 |
8,448 |
$1.36M |
| 74177 |
|
1,494 |
1,381 |
$1.16M |
| 80053 |
|
8,378 |
7,093 |
$658K |
| 74176 |
|
1,105 |
1,027 |
$648K |
| 70450 |
|
1,788 |
1,664 |
$119K |
| 99282 |
|
766 |
734 |
$113K |
| 80307 |
|
1,839 |
1,694 |
$89K |
| 72125 |
|
119 |
116 |
$44K |
| 99281 |
|
590 |
576 |
$39K |
| 96361 |
|
3,985 |
3,556 |
$39K |
| 73610 |
|
134 |
125 |
$27K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
303 |
270 |
$23K |
| 73562 |
|
86 |
83 |
$20K |
| 96366 |
|
364 |
334 |
$19K |
| 94640 |
|
973 |
864 |
$16K |
| 73130 |
|
74 |
70 |
$15K |
| 73630 |
|
100 |
96 |
$13K |
| 96375 |
|
4,921 |
4,209 |
$9K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
228 |
212 |
$7K |
| 76705 |
|
40 |
40 |
$6K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
37 |
37 |
$4K |
| 87635 |
|
219 |
211 |
$4K |
| 73110 |
|
15 |
13 |
$2K |
| 80050 |
|
14 |
13 |
$1K |
| 96374 |
|
5,858 |
5,230 |
$539.27 |
| 71045 |
|
4,882 |
4,481 |
$537.24 |
| 87186 |
|
607 |
567 |
$484.18 |
| 93005 |
|
3,904 |
3,390 |
$483.23 |
| 87428 |
|
2,878 |
2,775 |
$422.74 |
| 73030 |
|
26 |
25 |
$353.86 |
| 71046 |
|
461 |
425 |
$316.79 |
| 74022 |
|
12 |
12 |
$302.75 |
| 80048 |
|
1,351 |
1,194 |
$246.57 |
| 96372 |
|
3,506 |
3,268 |
$187.46 |
| 96365 |
|
1,647 |
1,528 |
$183.40 |
| 85025 |
|
8,936 |
7,497 |
$174.75 |
| 87880 |
|
2,765 |
2,676 |
$96.45 |
| 74018 |
|
557 |
537 |
$81.54 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
5,754 |
4,502 |
$80.46 |
| 87426 |
|
1,434 |
1,367 |
$80.23 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,520 |
1,802 |
$48.25 |
| 83605 |
|
971 |
805 |
$47.70 |
| 81025 |
|
2,201 |
2,076 |
$45.50 |
| 84484 |
|
3,651 |
2,623 |
$42.02 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,872 |
3,487 |
$37.24 |
| 83690 |
|
3,045 |
2,706 |
$35.44 |
| 83880 |
|
647 |
525 |
$30.15 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,002 |
1,770 |
$25.56 |
| 81001 |
|
4,063 |
3,736 |
$24.23 |
| 87086 |
|
2,207 |
2,051 |
$23.60 |
| 85027 |
|
783 |
713 |
$23.27 |
| 82550 |
|
462 |
420 |
$22.80 |
| 94760 |
|
242 |
203 |
$20.11 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
4,292 |
3,384 |
$19.68 |
| 83735 |
|
2,763 |
2,305 |
$19.42 |
| 36415 |
|
11,016 |
9,082 |
$18.42 |
| 87088 |
|
128 |
121 |
$16.72 |
| 82077 |
|
235 |
228 |
$12.44 |
| 81003 |
|
3,204 |
3,004 |
$12.19 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,143 |
1,979 |
$10.92 |
| J2060 |
Injection, lorazepam, 2 mg |
875 |
662 |
$10.38 |
| 85610 |
|
992 |
871 |
$8.86 |
| 87804 |
|
2,546 |
1,254 |
$8.85 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,220 |
728 |
$7.14 |
| 82962 |
|
731 |
438 |
$6.60 |
| 87081 |
|
2,070 |
2,016 |
$6.29 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
972 |
912 |
$0.00 |
| A9270 |
Non-covered item or service |
1,218 |
402 |
$0.00 |
| 83036 |
|
38 |
36 |
$0.00 |
| 96376 |
|
1,144 |
971 |
$0.00 |
| G0378 |
Hospital observation service, per hour |
296 |
156 |
$0.00 |
| 87807 |
|
464 |
454 |
$0.00 |
| 84703 |
|
1,386 |
1,308 |
$0.00 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
206 |
192 |
$0.00 |
| 80320 |
|
171 |
165 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
262 |
199 |
$0.00 |
| 87040 |
|
315 |
192 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
159 |
134 |
$0.00 |
| 85379 |
|
261 |
248 |
$0.00 |
| J3490 |
Unclassified drugs |
12 |
12 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
133 |
113 |
$0.00 |
| 71275 |
|
67 |
65 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
268 |
251 |
$0.00 |
| 87147 |
|
59 |
52 |
$0.00 |
| 94761 |
|
15 |
13 |
$0.00 |
| 87077 |
|
14 |
14 |
$0.00 |
| 85730 |
|
14 |
14 |
$0.00 |
| 90471 |
|
26 |
26 |
$0.00 |
| 80047 |
|
12 |
12 |
$0.00 |
| 93971 |
|
13 |
12 |
$0.00 |
| 87591 |
|
12 |
12 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
13 |
12 |
$0.00 |
| 12001 |
|
13 |
12 |
$0.00 |
| 84702 |
|
73 |
70 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
636 |
509 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
947 |
716 |
$0.00 |
| 96360 |
|
508 |
493 |
$0.00 |
| 80143 |
|
99 |
93 |
$0.00 |
| 80179 |
|
99 |
93 |
$0.00 |
| 82947 |
|
95 |
55 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
48 |
44 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
27 |
24 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
28 |
24 |
$0.00 |
| 90715 |
|
26 |
26 |
$0.00 |
| 93976 |
|
19 |
18 |
$0.00 |
| 87491 |
|
12 |
12 |
$0.00 |
| 84600 |
|
13 |
12 |
$0.00 |